REGENXBIO Inc.
RGNX
$6.72
$0.172.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.11% | -12.47% | 16.33% | -0.70% | -1.65% |
| Total Depreciation and Amortization | 1.57% | -2.22% | -3.09% | -3.58% | -0.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.95% | 20.61% | -36.91% | 38.28% | -1.62% |
| Change in Net Operating Assets | 92.07% | 250.37% | 50.52% | -188.44% | 1,580.42% |
| Cash from Operations | 22.01% | 10.88% | 17.96% | -36.05% | 17.50% |
| Capital Expenditure | -230.98% | 31.22% | 14.90% | 50.53% | 21.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.25% | 24,455.34% | -98.50% | -60.85% | -12.46% |
| Cash from Investing | -19.87% | 18,852.99% | -102.03% | -61.20% | -12.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.10% | 235.42% | -99.86% | 63,486.60% | -96.63% |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 32.37% | -19.34% | 14.42% | 7.48% | -10.50% |
| Cash from Financing | 28.71% | -14.95% | -107.82% | 1,109.24% | -148.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 179.18% | 97.92% | -170.37% | 518.46% | -20.53% |
